84
JHF 2008

JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Embed Size (px)

Citation preview

Page 1: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

JHF 2008

Page 2: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Advanced Lung Disease: Palliative and Terminal Care

John Hansen-FlaschenProfessor of MedicineUniversity of PennsylvaniaPhiladelphia, Pennsylvania

American Thoracic Society

Page 3: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania
Page 4: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Ischemic heart diseaseCerebrovascular diseaseLower resp infectionDiarrheal diseasePerinatal disordersCOPDTuberculosisMeaslesRoad traffic accidentsLung cancer

6th

1990

COPD Mortality WorldwideCOPD Mortality Worldwide

- & . 1997 Murray Lopez Lancet modified from GOLD2005 slide set

Page 5: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Ischemic heart diseaseCerebrovascular diseaseLower resp infectionDiarrheal diseasePerinatal disordersCOPDTuberculosisMeaslesRoad traffic accidentsLung cancer

Stomach CancerHIVSuicide

6th

3rd

- & . 1997 Murray Lopez Lancet 2005 modified from GOLD slide set

1990 2020

COPD Mortality WorldwideCOPD Mortality Worldwide

Page 6: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

United States Mortality 2006Top Five Medical Causes, per 100,000United States Mortality 2006Top Five Medical Causes, per 100,000

199.4180.8

51.140.4 38.5

00

5050

100100

150150

200200

250250

300300Heart DiseaseHeart Disease

CancerCancer

StrokeStroke

ChronicLung DiseaseChronicLung Disease

AccidentsAccidents

- U.S. National Vital Statistics Report, NCHS, 2008.

Page 7: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

United States Mortality 2006Top Five Medical Causes, per 100,000United States Mortality 2006Top Five Medical Causes, per 100,000

199.4180.8

51.140.4 38.5

00

5050

100100

150150

200200

250250

300300Heart DiseaseHeart Disease

CancerCancer

StrokeStroke

ChronicLung DiseaseChronicLung Disease

AccidentsAccidents

- U.S. National Vital Statistics Report, NCHS, 2008.

124,614

Page 8: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Burden of COPD in the USBurden of COPD in the US

• Between 2000 and 2005, COPD was the underlying cause of death for 718,077 persons.

• In 2005, COPD was the underlying cause of death for approximately1 person in 20.

- Morbidity Mortality Weekly Report, November 17 2008 / 57:1229.

Page 9: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

American Thoracic Society Documents

An Official American Thoracic Society Clinical Policy Statement:

Palliative Care for Patients with Respiratory Diseases and Critical Illnesses

Paul N. Lanken, Peter B. Terry, Horace M. DeLisser, Bonnie F. Fahy,John Hansen-Flaschen, John E. Heffner, Mitchell Levy, Richard A. Mularski, Molly L. Osborne, Thomas J. Prendergast, Graeme Rocker, William J. Sibbald, Benjamin Wilfond and James R. Yankaskason behalf of the ATS End-of-Life Care Task Force

American Journal of Respiratory and Critical Care MedicineVol 177. pp. 912-927, (2008).© 2008 American Thoracic Society

Page 10: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Palliative care aims to prevent and relieve suffering by early identification, assessment, and treatment of pain and other types of physical, psychological, emotional, and spiritual distress.

- World Health Organization

Palliative Care

Page 11: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Current Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative Care

- Lanken PN et al. Am J Respir Crit Care Med 177:912, 2008.

Page 12: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Current Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative Care

- Lanken PN et al. Am J Respir Crit Care Med 177:912, 2008.

Page 13: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Current Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative Care

- Lanken PN et al. Am J Respir Crit Care Med 177:912, 2008.

Page 14: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Current Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative CareCurrent Concepts: Palliative Care

- Lanken PN et al. Am J Respir Crit Care Med 177:912, 2008.

Page 15: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Case #1A 74-year-old woman was transferred to the medical intensive care unit for further management of respiratory failure associated with:

• Very severe chronic obstructive lung disease• Severe mitral stenosis and coronary artery disease• Diabetes

Page 16: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Case #1She lived alone.

Over the past 6 years, her exercise tolerance had declined until she was unable to move beyond her bed and a nearby chair and had frequent experiences of dyspnea at rest.

In the past year, she was hospitalized repeatedly for fluid overload or respiratory distress.

Page 17: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Case #1In the ICU, she became continuously dependent on mechanical ventilation, vasopressors and hemodialysis. Her mental status waxed and waned.

Two of 8 children visited regularly and insisted that “everything be done” to prolong her life. They repeatedly objected to the use of pain and sedating medications.

The woman survived in the ICU for 9 months until she died of septic shock despite maximal life-supporting therapy.

Page 18: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania
Page 19: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Alleviation of Distress

• Counseling and Coordination of Care

Palliative CareAdvanced Lung Disease

Page 20: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Alleviation of Distress

• Counseling and Coordination of Care

Palliative CareAdvanced Lung Disease

Page 21: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Dyspnea• Cough• Psychological Distress

Anxiety/Panic Depression Cognitive Impairment Delirium

Distress inAdvanced Lung disease

Page 22: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Dyspnea• Cough• Psychological Distress

o Anxiety/Panico Depressiono Cognitive Impairmento Delirium

Distress inAdvanced Lung disease

Page 23: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

The subjective sensation ofbreathing discomfort.

- American Thoracic Society Statement on Dyspnea,1998.

Dyspnea

Page 24: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

The subjective sensation ofbreathing discomfort.

- American Thoracic Society Statement on Dyspnea,1998.

Dyspnea

Page 25: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania
Page 26: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

- Shumway NM et al. Respir Med 102:27, 2008.

Physician vs PatientPerception of Dyspnea in

Severely Ill Hospitalized Patients

Page 27: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Dyspnea

• Increased Work or Effort

• Chest Tightness• Air Hunger

at least three types

Page 28: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Dyspnea

• Increased Work or Effort

• Chest Tightness• Air Hunger

at least three types

Page 29: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

The conscious perception of the urge to breathe. The frightening or threatening sensation of not getting enough air.

Air Hunger

Page 30: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Dyspnea

• Dyspnea on Exertion• Paroxysmal Dyspnea• Sustained Dyspnea at Rest

at least three situations

Page 31: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Dyspnea

• Dyspnea on Exertion• Paroxysmal Dyspnea• Sustained Dyspnea at Rest

at least three situations

Page 32: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Dyspnea

• Dyspnea on Exertion• Paroxysmal Dyspnea• Sustained Dyspnea at Rest

at least three situations

Page 33: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Strong evidence supports treatmentof dyspnea on exertion with:

b-agonists opioids oxygen pulmonary rehabilitation

Treatment forDyspnea on Exertion in COPD

Conclusions of a systematic reviewAmerican College of Physicians

Clinical Efficacy Assessment Subcommittee

- Lorenz KA et al. Ann Intern Med. 148:147, 2008.

Page 34: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Strong evidence supports treatmentof dyspnea on exertion with:

o -agonistso opioidso oxygeno pulmonary rehabilitation

Treatment forDyspnea on Exertion in COPD

Conclusions of a systematic reviewAmerican College of Physicians

Clinical Efficacy Assessment Subcommittee

- Lorenz KA et al. Ann Intern Med. 148:147, 2008.

Page 35: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Opioids for DyspneaOpioids for Dyspnea

- Jennings A-L, et al. Thorax; 57:939, 2002.

Page 36: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Strong evidence supports treatmentof dyspnea on exertion with:

b-agonists opioids oxygen pulmonary rehabilitation

Treatment forDyspnea on Exertion in COPD

Conclusions of a systematic reviewAmerican College of Physicians

Clinical Efficacy Assessment Subcommittee

- Lorenz KA et al. Ann Intern Med. 148:147, 2008.

Page 37: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Oxygen forExertional Dyspnea

For desaturators, distance walked in6 min increased 22%and Borg scale dyspnea decreased 36% with supplemental oxygen,

For non desaturators, Borg scale dyspnea decreased 47%, but distance walkeddid not improve.

- Jolly EC et al. Chest. 20:437, 2001.

Page 38: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Oxygen forExertional Dyspnea

For desaturators, distance walked in6 min increased 22%and Borg scale dyspnea decreased 36% with supplemental oxygen,

For non desaturators, Borg scale dyspnea decreased 47%, but distance walkeddid not improve.

- Jolly EC et al. Chest. 20:437, 2001.

Page 39: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Strong evidence supports treatmentof dyspnea on exertion with:

b-agonists opioids oxygen pulmonary rehabilitation

Treatment forDyspnea on Exertion in COPD

Conclusions of a systematic reviewAmerican College of Physicians

Clinical Efficacy Assessment Subcommittee

- Lorenz KA et al. Ann Intern Med. 148:147, 2008.

Page 40: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Dyspnea

• Dyspnea on Exertion• Paroxysmal Dyspnea• Sustained Dyspnea at Rest

at least three situations

Page 41: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Dyspnea

• Dyspnea on Exertion• Paroxysmal Dyspnea• Sustained Dyspnea at Rest

at least three situations

Page 42: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• supplemental oxygen• opioids and

benzodiazepines• non-invasive mechanical

ventilation• intubation for deep

sedation

Palliation ofSustained Dyspnea at Rest

Page 43: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• supplemental oxygen• opioids and

benzodiazepines• non-invasive mechanical

ventilation• intubation for deep

sedation

Palliation ofSustained Dyspnea at Rest

Page 44: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• supplemental oxygen• opioids and

benzodiazepines• non-invasive mechanical

ventilation• intubation for deep

sedation

Palliation ofSustained Dyspnea at Rest

Page 45: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Morphine and MidazolamMorphine and Midazolamfor Dyspneafor Dyspnea

Morphine and MidazolamMorphine and Midazolamfor Dyspneafor Dyspnea

- Navigante A, et al. J Pain Symptom Management 57:939, 2002.

Mo MorphineMi MidazolamMM Morphine and Midazolam

Terminally ill cancer patients at 24 hours

Percent experiencing pain relief

Page 46: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• supplemental oxygen• opioids and

benzodiazepines• non-invasive mechanical

ventilation• intubation for deep

sedation

Palliation ofSustained Dyspnea at Rest

Page 47: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

NoninvasiveVentilatory Support for Dyspnea at Rest

NoninvasiveVentilatory Support for Dyspnea at Rest

Page 48: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Exacerbation of COPDExacerbation of COPDNon-invasive Mechanical VentilationNon-invasive Mechanical Ventilation

for Relief of Dyspnea at Restfor Relief of Dyspnea at Rest

Exacerbation of COPDExacerbation of COPDNon-invasive Mechanical VentilationNon-invasive Mechanical Ventilation

for Relief of Dyspnea at Restfor Relief of Dyspnea at Rest

- Keenan SP, et al. Resp Care 50:610, 2005.

only 12 of 25randomized tointermittent NIMV(BiPAP)completed 3 days of treatment

Page 49: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• supplemental oxygen• opioids and

benzodiazepines• non-invasive mechanical

ventilation• intubation for deep

sedation

Palliation ofSustained Dyspnea at Rest

Page 50: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Mechanically Ventilated Patients

Shortness of Breath 11%

Mild 8%

Moderate 2%

Severe 1%

No Shortness of Breath 89%

- Karampela I, et al. Respiratory Care 47:1158, 2002.

Are you short of breath right now?

Page 51: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Dyspnea• Cough• Psychological Distress

Anxiety/Panic Depression Cognitive impairment Delirium

Distress inAdvanced Lung disease

Page 52: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Steroids for Cough inSteroids for Cough inIdiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis

Steroids for Cough inSteroids for Cough inIdiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis

- Hope-Gill BDM, et al. AJRCCM 168:996, 2003.

Page 53: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Dyspnea• Cough• Psychological Distress

o Anxiety/Panico Depressiono Cognitive Impairmento Delirium

Distress inAdvanced Lung disease

Page 54: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Prevalence of anxiety & depressionPrevalence of anxiety & depressionin chronic breathing disordersin chronic breathing disorders

Prevalence of anxiety & depressionPrevalence of anxiety & depressionin chronic breathing disordersin chronic breathing disorders

204 outpatients at the Houston VA 204 outpatients at the Houston VA

- Kunik ME, et al. Chest 127:1205, 2005.

anxiety 51%

depression 39%

both 26%

either of both 65%

Page 55: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

COPD in Patients withSerious Mental IllnessesCOPD in Patients with

Serious Mental Illnesses

National Health & Nutrition Examination Study III National Health & Nutrition Examination Study III

Mental Illness Control

Chronic Bronchitis

19.5% 6.1%

Emphysema 7.9% 1.5%

- Himelhoch S, et al. Am J Psychiat 161:2317, 2004

Page 56: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

PRIME-MD ScreenPRIME-MD Screenfor Anxiety and Depressionfor Anxiety and Depression

PRIME-MD ScreenPRIME-MD Screenfor Anxiety and Depressionfor Anxiety and Depression

DepressionIn the past month have you been bothered a

lot by:1. little interest or pleasure in doing things?2. feeling down, depressed or hopeless?

AnxietyIn the past month, have you been bothered a lot

by:3. “nerves” or feeling anxious or on edge?4. worrying about a lot of different things?5. During the last month have you had an

anxiety attack?

1 positive response: highly sensitiveall positive responses: highly specific

- Kunik ME et al. Psychosomatics 48:1. 2007.

Page 57: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Treatment of Anxiety and DepressionTreatment of Anxiety and Depressionin Severe COPDin Severe COPD

Treatment of Anxiety and DepressionTreatment of Anxiety and Depressionin Severe COPDin Severe COPD

• Few small studies have reported conflicting results for the treatment of anxiety with buspirone and depression with antidepressants.

• Similarly mixed results for treatment of anxiety with cognitive behavioral therapy.

• Several studies have reported benefits of pulmonary rehabilitation with education sessions for treatment of anxiety and depression.

• Few small studies have reported conflicting results for the treatment of anxiety with buspirone and depression with antidepressants.

• Similarly mixed results for treatment of anxiety with cognitive behavioral therapy.

• Several studies have reported benefits of pulmonary rehabilitation with education sessions for treatment of anxiety and depression.

- Hill, K, et al. E Respir J.; 31:667, 2008.

Evidence Basis

Page 58: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Treatment ofTreatment ofAnxiety and DepressionAnxiety and Depression

in Severe COPDin Severe COPD

Treatment ofTreatment ofAnxiety and DepressionAnxiety and Depression

in Severe COPDin Severe COPD

• patient education

• antidepressants: sertraline, bupropion, fluoxetine

• buspirone or a benzodiazepine in moderate doses

• cognitive and behavioral therapy

• patient education

• antidepressants: sertraline, bupropion, fluoxetine

• buspirone or a benzodiazepine in moderate doses

• cognitive and behavioral therapy

- Brenes, GA. Psychosomatic Med 65:963, 2003.

Page 59: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Alleviation of Distress

• Counseling and Coordination of Care

Palliative CareAdvanced Lung Disease

Page 60: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

• Alleviation of Distress

• Counseling and Coordination of Care …

…near the end of life

Palliative CareAdvanced Lung Disease

Page 61: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania
Page 62: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Barriers to DiscussingBarriers to DiscussingEnd-of-Life CareEnd-of-Life Care

Barriers to DiscussingBarriers to DiscussingEnd-of-Life CareEnd-of-Life Care

• I’d rather concentrate on staying alive than talk about death.

• I’m not sure which physician will be taking care of me if I get very sick.

• I’d rather concentrate on staying alive than talk about death.

• I’m not sure which physician will be taking care of me if I get very sick.

commonly endorsed by patients

- Knauft E, et al. Chest 127:2188, 2005.

Page 63: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Barriers to DiscussingBarriers to DiscussingEnd-of-Life CareEnd-of-Life Care

Barriers to DiscussingBarriers to DiscussingEnd-of-Life CareEnd-of-Life Care

• There is too little time during our appointments to discuss everything we should (57%).

• I worry that discussing end-of-life care will take away hope(20%).

• There is too little time during our appointments to discuss everything we should (57%).

• I worry that discussing end-of-life care will take away hope(20%).

- Knauft E, et al. Chest 127:2188, 2005.

commonly endorsed by patients

Page 64: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Advanced PlanningAdvanced Planningfor End of Life Carefor End of Life CareAdvanced PlanningAdvanced Planningfor End of Life Carefor End of Life Care

• Offer an honest prognosis

• Promote, document and coordinate advanced planning for health care

• Offer an honest prognosis

• Promote, document and coordinate advanced planning for health care

Page 65: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Advanced Planningfor End of Life CareAdvanced Planningfor End of Life Care

• Offer an honest prognosis

• Promote, document and coordinate advanced planning for health care

• Offer an honest prognosis

• Promote, document and coordinate advanced planning for health care

Page 66: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

COPD: Staging by FEVCOPD: Staging by FEV11COPD: Staging by FEVCOPD: Staging by FEV11

- Nishimura K, et al. Chest; 212:1434, 2002.

Page 67: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

COPD: Staging by FEVCOPD: Staging by FEV11COPD: Staging by FEVCOPD: Staging by FEV11

- Nishimura K, et al. Chest; 212:1434, 2002.

Page 68: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

- Celli, BR et al. N Engl J Med 2004;350:1005.

COPD BODE Survival IndexCOPD BODE Survival Index

Body Mass IndexAirflow ObstructionDyspneaExercise Capacity

Page 69: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

COPDCOPDEmerging Profile of PatientsEmerging Profile of Patients

in the Last Year of Lifein the Last Year of Life

COPDCOPDEmerging Profile of PatientsEmerging Profile of Patients

in the Last Year of Lifein the Last Year of Life severely reduced FEV1

severely reduced and declining performance status

multiple recent exacerbations Prior ICU admissions co-morbidities low body weight depressed lives alone

Page 70: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

COPDCOPDEmerging Profile of PatientsEmerging Profile of Patients

in the Last Year of Lifein the Last Year of Life

COPDCOPDEmerging Profile of PatientsEmerging Profile of Patients

in the Last Year of Lifein the Last Year of Life severely reduced FEV1

severely reduced and declining performance status

multiple recent hospitalizations Prior ICU admissions co-morbidities low body weight depressed lives alone

Page 71: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

“Have you been thinking about how or when you might die?”

“Have you been thinking about how or when you might die?”

- Quill TE.JAMA; 284:2502 2000.

Page 72: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

“Some people in your current condition live 1 or 2 years or longer.

But your lung reserve is so reduced now that you might die at any time from a complication of your disease.”

“Some people in your current condition live 1 or 2 years or longer.

But your lung reserve is so reduced now that you might die at any time from a complication of your disease.”

Page 73: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

“Some people in your current condition live 1 or 2 years or longer.

But your lung reserve is so reduced now that you might die at any time from a complication of your disease.”

“Some people in your current condition live 1 or 2 years or longer.

But your lung reserve is so reduced now that you might die at any time from a complication of your disease.”

Page 74: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

“Hope and expect for the

best.

Prepare for the worst.”

“Hope and expect for the

best.

Prepare for the worst.”

-Back AL et al.Ann Intern Med 138:439, 2003

Page 75: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Preparing aMedical Advance Directive

Preparing aMedical Advance Directive

• Based upon a structured discussion between patient, designated proxy and physician.

• A written Medical Advance Directive summarizes the discussion and is signed by all 3 participants.

• Based upon a structured discussion between patient, designated proxy and physician.

• A written Medical Advance Directive summarizes the discussion and is signed by all 3 participants.

Page 76: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Preparing aMedical Advance Directive

Preparing aMedical Advance Directive

• Based upon a structured discussion between patient, designated proxy and physician.

• A written Medical Advance Directive summarizes the discussion and is signed by all 3 participants.

• Based upon a structured discussion between patient, designated proxy and physician.

• A written Medical Advance Directive summarizes the discussion and is signed by all 3 participants.

Page 77: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Preparing aPreparing aMedicalMedical Advance Directive Advance Directive

Preparing aPreparing aMedicalMedical Advance Directive Advance Directive

• Preferences for initiating and continuinglife support.

• Dying at home or in a hospital.

• Preferred facilities for medical care.

• Plan for the “what ifs.”

• Preferences for initiating and continuinglife support.

• Dying at home or in a hospital.

• Preferred facilities for medical care.

• Plan for the “what ifs.”

Page 78: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania
Page 79: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Penn Hospice at Rittenhouse

Page 80: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Case #2A 58-year-old school teacher was found to have idiopathic pulmonary fibrosis. He declined consideration for lung transplantation.

Over 4 years, his disease progressed until he required high-flow supplemental oxygen.

Page 81: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Case #2The pulmonologist met with the man and his wife to discuss advanced medical planning.

The wife wrote a letter summarizing the conversation. All three participants signed the letter.

As symptoms progressed, treatment was initiated with sertraline and lorezepam for anxiety and depression and low-dose prednisone for cough.

Page 82: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Case #2Three months later, the man was hospitalized and emergently intubated for respiratory failure accompanied by air hunger at rest.

Three days later, in accordance with his medical advanced directive, he was extubated under palliative sedation with his wife at the bedside.

Page 83: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania

Palliative care aims to prevent and relieve suffering by early identification, assessment, and treatment of pain and other types of physical, psychological, emotional, and spiritual distress.

- World Health Organization

Palliative Care

Page 84: JHF 2008. Advanced Lung Disease: Palliative and Terminal Care John Hansen-Flaschen Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania